Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241]

The authors regret that Carles Fabregat-Franco's name was incorrectly given in the original article as Carles Fabregat. This has now been corrected in the online article. The correct author details are: Carles Fabregat-Franco b b Gastrointestinal Cancer Unit, Vall d’Hebron University Hospital & Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain The authors would like to apologize for any inconvenience caused. Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinomaEuropean Journal of CancerVol. 171PreviewBiliary tract cancers are rare malignancies with a poor prognosis and scarce therapeutic strategies. The significance of BRCAness in this setting is already unknown. Full-Text PDF